‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
JAMA Neurology Author Interviews
JC Virus in CD34+ and CD19+ Cells in Patients With Multiple Sclerosis Treated With Natalizumab
30
00:00:00
/ 00:07:48
30